What does Arbutus Biopharma Corp (ABUS) Stock have to offer?

Jefferies raised the price target for the Arbutus Biopharma Corp (NASDAQ:ABUS) stock from “a Hold” to “a Buy”. The rating was released on February 02, 2022, according to finviz. The research report from H.C. Wainwright has initiated the stock to Buy, with a price target set at $10. The stock was resumed by JMP Securities, […]

Arbutus Biopharma Corp (ABUS) Stock to return to profitability in the near future

Jefferies raised the price target for the Arbutus Biopharma Corp (NASDAQ:ABUS) stock from “a Hold” to “a Buy”. The rating was released on February 02, 2022, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report […]

Arbutus Biopharma Corp (NASDAQ:ABUS) Stock Price Settled at $2.36: What’s Resulting?

Jefferies raised the price target for the Arbutus Biopharma Corp (NASDAQ:ABUS) stock from “a Hold” to “a Buy”. The rating was released on February 02, 2022, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report […]